Elizabeth H.Z. Thompson - Dec 30, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP, Research & Development
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Dec 30, 2022
Transactions value $
-$1,075,296
Form type
4
Date filed
1/4/2023, 03:18 PM
Previous filing
Jul 20, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +19.1K +273.43% 26K Dec 30, 2022 Direct F1
transaction HZNP Ordinary Shares Tax liability -$1.08M -9.45K -36.31% $113.80 16.6K Dec 30, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -7.26K -100% $0.00* 0 Dec 30, 2022 Ordinary Shares 7.26K Direct F1, F2
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -4.66K -50% $0.00 4.66K Dec 30, 2022 Ordinary Shares 4.66K Direct F1, F3
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -7.14K -33.33% $0.00 14.3K Dec 30, 2022 Ordinary Shares 7.14K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one ordinary share of the Issuer.
F2 The final tranche of ordinary shares subject to the RSU vested on December 30, 2022.
F3 The remaining ordinary shares subject to the RSU vest on January 5, 2024.
F4 The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025.